Skip to main content
. 2021 Dec 29;11(1):83. doi: 10.3390/antiox11010083

Figure 5.

Figure 5

Effect of adenine-induced chronic kidney disease (CKD), resveratrol, or resveratrol butyrate ester on the gut microbiome. (A) α-Diversity measured by the abundance-based coverage estimator (ACE) index. (B) β-Diversity using the partial least squares discriminant analysis (PLS-DA). (C) Relative abundance of the top five phyla of the gut microbiota. Relative abundance of the phyla (D) Actinobacteria and (E) Verrucomicrobia. N = 8/group; * p < 0.05; ** p < 0.01.